Indication

Qutenza^® is indicated for the management of neuropathic pain associated with postherpetic neuralgia.

About Qutenza^® (capsaicin) 8% patch

Qutenza^® contains capsaicin in a local dermal delivery system. The capsaicin in Qutenza^® is a synthetic equivalent of the naturally occurring compound found in chili peppers.

Important Safety Information

Qutenza^® is administered by a physician or a health professional under the close supervision of a physician. Qutenza^® may be administered every 3 months or as warranted by the return of pain, but not more frequently than every 3 months. In clinical trials, the most common adverse reactions were application site redness, pain, itching, and papules. The majority of these reactions were transient and self limited. Among patients treated with Qutenza^®, 1% discontinued prematurely due to an adverse event. Serious adverse reactions included application-site pain and increased blood pressure. Blood pressure increases during or shortly after Qutenza^® treatment were on average less than 10 mm Hg, although some patients had greater increases and these changes lasted for approximately 2 hours after patch removal.

© NeurogesX, Inc. 2010 All Rights Reserved